# Evaluate the Efficacy and Safety of DHA in the Adjuvant Treatment of Children With ASD.

> **NCT03620097** · NA · COMPLETED · sponsor: **Maimónides Biomedical Research Institute of Córdoba** · enrollment: 60 (actual)

## Conditions studied

- ASD

## Interventions

- **DIETARY_SUPPLEMENT:** EuPoly-3 DHA Infant
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03620097
- **Lead sponsor:** Maimónides Biomedical Research Institute of Córdoba
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-21
- **Primary completion:** 2015-12-02
- **Final completion:** 2015-12-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03620097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03620097, "Evaluate the Efficacy and Safety of DHA in the Adjuvant Treatment of Children With ASD.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03620097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*